Abstract
Lung cancer is a disease with high incidence and mortality (1). The prognosis for patients with lung cancer is most favorable when tumors are detected early in a surgically resectable stage of non-small cell lung cancer (NSCLC). Methods that can increase the percentage of cases of lung cancer detected in early stage may theoretically lead to a decrease in mortality. However, in the past, screening programs for early detection of lung cancer that used chest X-ray of the thorax with or without sputum cytology have not been successful in reducing the high numbers of lung cancer deaths (2–5). Therefore, new approaches that use genetic alterations as potential biomarkers may be beneficial for early detection.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Boring, C. C., Squires, T. S., Tong, T., et al. (1994) Cancer statistics, 1994. CA. Cancer. J. Clin. 44, 7–26.
Frost, J. K., Ball, W. C., Levin, M. L., Tockman, M. S., Baker, R. R., Carter, D., et al. (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am. Rev. Respir. Dis. 130, 549–554.
Flehinger, B. J., Melamed, M. R., Zaman, M. B., Heelan, R. T., Perchick, W. B., and Martini, N. (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am. Rev. Respir. Dis. 130, 555–560.
Fontana, R. S., Sanderson, D. R., Taylor, W. F., Woolner, L. B., Miller, W. E., Muhm, J. R., et al. (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am. Rev. Respir. Dis. 130, 561–565.
Frost, J. K., Ball, W. C., and Levin, W. L., (1984) Early lung cancer detection: summary and conclusions. Am. Rev. Respir. Dis. 130, 565–570.
Vachtenheim, J., Horáková, I., Novotná, H., Opálka, P., and Roubková, H. (1995) Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Clin. Cancer Res. 1, 359–365.
Nedergaard, T., Guldberg, P., Ralfklaer, E., and Zeuthen, J. (1997) A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin’s lymphoma. Int. J. Cancer 71, 364–369.
Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P., et al. (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256, 102–105.
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., et al. (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252, 706–709.
Tada, M., Omata, M., Kawai, S., Saisho, H., Ohto, M., Saiki, R. K., et al. (1993) Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 53, 2472–2474.
Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M., and Sidransky, D. (1994) Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 54, 1634–1637.
Mills, N. E., Fishman, C. L., Scholes, J., Anderson, S. E., Rom, W. N., and Jacobson, D. R., (1995) Detection of K-ras oncogene mutations in bron-choalveolar lavage fluid for lung cancer diagnosis. J. Natl. Cancer I 87(14), 1056–1060.
Kelly, K. (1994) Evaluation of K-ras mutations in sputum samples by single-stranded conformation polymorphism. Lung 11(Suppl 1), 59.
Takeda, S., Ichii, S., and Nakamura, Y. (1993) Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum. Mutat. 2, 112–117.
Yakubovskaya, M. S., Spiegelman, V., Luo, F. C., Malaev, S., Salnev, A., Zborovskaya, I., et al. (1995) High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int. J. Cancer 63, 810–814.
Lehman, T. A., Scott, F., Seddon, M., Kelly, K., Dempsey, E. C., Wilson, V. L., et al. (1996) Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction. Anal. Biochem. 239, 153–159.
Marchetti, A., Buttitta, F., Carnicelli, V., Pellegrini, S., Bertacca, G., Merlo, G., et al. (1997) Enriched SSCP: A highly sensitive method for detection of unknown mutations. Application to the molecular diagnosis of lung cancer in sputum samples. Diagn. Mol. Pathol. 6(4), 185–191.
Ronai, Z., Yakubovskaya, M. S., Zhang, E., and Belitsky, G. A. (1996) K-ras mutation in sputum of patients with or without lung cancer. J. Cell Biochem. 25S, 172–176.
Shiono, S., Omoe, K., and Endo A. (1996) K-ras gene mutation in sputum samples containing atypical cells and adenocarcinoma cells in the lung. Carcinogenesis 17, 1683–1686.
Nickerson, D. A., Kaiser, R., Lappin, S., Stewart, J., and Hood, L. (1990) Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc. Natl. Acad. Sci. USA 87, 8923–8927.
Somers, V. A. M. C., Moerkerk, P. T. M., Murtagh, J. J., Jr., and Thunnissen, F. B. J. M. (1994) A rapid, reliable method for detection of known point mutations: Point-EXACCT. Nucleic Acids Res. 22, 4840–4841.
Somers, V. A. M. C., Leimbach, D. A., Murtagh, J. J. J., and Thunnissen, F. B. J. M. (1998) Exonuclease enhances hybridization efficiency: improved direct cycle sequencing and point mutation detection. Biochim. Biophys. Acta 1379(1), 42–52.
Somers, V. A. M. C., Leimbach, D. A., Theunissen, P. H. M. H., Murtagh, J. J. J., Holloway, B., Ambergen, A. W., et al. (1998) Validation of the Point-EXACCT method in non-small cell lung carcinomas. Clin. Chem. 44(7), 1404–1409.
Bos, J. L. (1988) The ras gene family and human carcinogenesis. Mutat. Res. 195, 255–271.
Park, J. G., Oie, H. K., Sugarbaker, P. H., Henslee, J. G., Chen, T. R., Johnson, B. E., et al. (1987) Characteristics of cell lines established from human colorectal carcinoma. Cancer Res. 47, 6710–6718.
Valenzuela, D. and Groffen, J. (1986) Four human carcinoma cell lines with novel mutations in positions 12 of c-K-ras oncogene. Nucleic Acids Res. 14(2), 843–851.
Capon, D. J., Seeburg, P. H., McGrath, J. P., Hayflick, J. S., Edma, U., Levinson, A. D., et al. (1983) Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature 304, 507–513.
Mills, N. E., Fishman, C. L., Rom, W. M., Dubin, N., and Jacobson, D. R. (1995) Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55, 1444–1447.
Somers, V. A. M. C., Pietersen, A. M., Theunissen, P. H. M. H., and Thunnissen, F. B. J. M. (1998) Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by Point-EXACCT. J. Clin. Oncol. 16(9), 3061–3068.
WHO (1982) The World Health Organization histological typing of lung tumours, second edition. Am. J. Clin. Pathol. 77(2), 123–136.
Huang, M. M., Arnheim, N., and Goodman, M. F. (1992) Extension of base mispairs by Taq DNA polymerase: implications for single nucleotide discrimination in PCR. Nucleic Acids Res. 20(17), 4567–4573.
Cline, J., Braman, J. C., and Hogrefe, H. H. (1996) PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids. Res. 24, 3546–3551.
Saccomano, G., Archer, V. E., Auerbach, O., Saunders, R. P., and Brennan, L. M. (1974) Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 33, 256–270.
Murakami, I., Fujiwara, Y., Yamaoka, N., Hiyama, K., Ishioka, S., and Yamakido, M. (1996) Detection of p53 gene mutations in cytopathology and biopsy specimens from patients with lung cancer. Am. J. Respir. Crit. Care Med. 154, 1117–1123.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855–4878.
Anon. (1997) Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am. J. Respir. Crit. Care Med. 156, 320–332.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Somers, V.A.M.C., Thunnissen, F.B.J.M. (2003). Detection of K-ras Point Mutations in Sputum from Patients with Adenocarcinoma of the Lung by Point-EXACCT. In: Driscoll, B. (eds) Lung Cancer. Methods in Molecular Medicine™, vol 75. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-324-0:305
Download citation
DOI: https://doi.org/10.1385/1-59259-324-0:305
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-920-9
Online ISBN: 978-1-59259-324-8
eBook Packages: Springer Protocols